CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Smith, EML; Pang, H; Cirrincione, C; Fleishman, SB; Paskett, ED; Fadul, CE; Knox, C; Shapiro, CL; Gilman, P; Canc, LGB

Published Date

  • June 20, 2012

Published In

Volume / Issue

  • 30 / 18

International Standard Serial Number (ISSN)

  • 0732-183X